UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
November 9, 2022 5:00 P.M.
Form:
S-1
CIK:
0001781174
Company Name:
Acrivon Therapeutics, Inc.
File Number:
333-267911